USMLE Step 1 practice question: Conjugate polysaccharide vaccines: T cell–dependent response via linked recognition

USMLE Step 1ImmunologyImmunology

A 2-month-old girl is brought to the physician for a well-child examination. She was born at term after an uncomplicated pregnancy and is breastfeeding well. Her weight and length are at the 50th percentile. Physical examination shows no abnormalities. Scheduled immunizations include a pneumococcal vaccine in which capsular polysaccharides from several serotypes of Streptococcus pneumoniae are covalently linked to a nontoxic mutant of diphtheria toxin. Her grandmother, who accompanies her, asks why the infant cannot receive the unconjugated polysaccharide vaccine that she herself received years ago. The physician explains that unconjugated polysaccharide vaccines produce poor and short-lived responses in children younger than 2 years.

Which of the following best explains the improved immune response to the conjugate vaccine in this patient?

  1. Multivalent polysaccharide cross-links B-cell receptors, activating B cells without T-cell help
  2. Polysaccharide-specific B cells present carrier-derived peptides on MHC class II to helper T cells
  3. The carrier protein is presented on MHC class I, generating cytotoxic T cells against the bacteria
  4. Splenic marginal zone B cells, which are fully mature at birth, respond to the carrier protein
  5. The carrier protein protects maternal IgG from degradation, prolonging passive immunity
Show answer and explanation

Correct answer: B. Polysaccharide-specific B cells present carrier-derived peptides on MHC class II to helper T cells

Bacterial capsular polysaccharides are T cell–independent antigens. Their repeating epitopes cross-link many B-cell receptors simultaneously, activating B cells (largely splenic marginal zone and B-1 cells) without help from CD4+ T cells. Because polysaccharides cannot be processed and presented on MHC class II, T-cell help is not recruited; the result is mainly low-affinity IgM, little class switching, no affinity maturation, and no immunologic memory (no booster effect). Children younger than about 2 years respond poorly to these antigens because their marginal zone B cells and T-independent responses are immature. This is why young children are highly susceptible to encapsulated organisms (S. pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis) and why plain polysaccharide vaccines (eg, PPSV23) are not used in infants.

Conjugation converts the polysaccharide into a T cell–dependent antigen. A B cell whose receptor recognizes the polysaccharide internalizes the entire conjugate, processes the attached protein carrier (eg, CRM197, a nontoxic diphtheria toxin mutant, or tetanus toxoid), and presents carrier-derived peptides on MHC class II. Carrier-specific CD4+ T helper cells recognize these peptides and provide help through CD40L–CD40 interaction and cytokines (eg, IL-4, IL-21)—a process called linked recognition. This drives germinal center formation, class switching to IgG, affinity maturation, and generation of long-lived plasma cells and memory B cells, producing a robust, boostable anti-polysaccharide antibody response even in infants. Conjugate vaccines include the Hib, pneumococcal conjugate (eg, PCV15, PCV20), and meningococcal conjugate (MenACWY) vaccines. In the United States, PCV is given at 2, 4, 6, and 12–15 months of age.

High-yield summary: Polysaccharide alone = T-independent → IgM, no memory, poor response in children <2 years. Polysaccharide + protein carrier = T-dependent → B cell presents carrier peptide on MHC II to CD4+ T cells → class switching (IgG), affinity maturation, and memory.

Why the other options are wrong

  • A. Multivalent polysaccharide cross-links B-cell receptors, activating B cells without T-cell help — Cross-linking of B-cell receptors by repetitive polysaccharide epitopes is the T cell–independent mechanism of unconjugated vaccines; this pathway is weak in children younger than 2 years and produces IgM without memory.
  • C. The carrier protein is presented on MHC class I, generating cytotoxic T cells against the bacteria — Exogenous protein antigens in nonlive vaccines are processed mainly through the MHC class II pathway; protection against extracellular encapsulated bacteria depends on opsonizing antibodies, not cytotoxic T cells.
  • D. Splenic marginal zone B cells, which are fully mature at birth, respond to the carrier protein — Splenic marginal zone B cells, which mediate T-independent responses to polysaccharides, are immature in infants and do not reach full function until about 2 years of age—this immaturity is why unconjugated vaccines fail in young children.
  • E. The carrier protein protects maternal IgG from degradation, prolonging passive immunity — Maternal IgG transferred across the placenta (via the neonatal Fc receptor) wanes over the first 6 months regardless of vaccination; carrier proteins do not prolong passive immunity.

Key point

Conjugating capsular polysaccharides to a protein carrier converts a T cell–independent antigen into a T cell–dependent antigen, enabling class switching, affinity maturation, and memory in infants.

Memory hook

Sugar alone can't talk to T cells; conjugation gives the sugar a protein ‘translator’ on MHC II → IgG + memory in babies.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Hereditary angioedema: C1 inhibitor deficiency and bradykininUSMLE Step 1 · ImmunologyChronic aortic regurgitationUSMLE Step 1 · CardiovascularPharmacokinetics: volume of distribution and oral loading doseUSMLE Step 1 · PharmacologyAutosomal recessive recurrence risk (cystic fibrosis, unaffected sibling = 2/3 carrier)USMLE Step 1 · GeneticsAcyclovir-resistant HSV: thymidine kinase deficiencyUSMLE Step 1 · MicrobiologyCisplatin toxicity (ototoxicity, nephrotoxicity, hypomagnesemia): DNA cross-linkingUSMLE Step 1 · Hematology/Oncology

All free questions →